A lower frequency of peripheral blood CD14+CD16– monocytes was associated with their increase in bone marrow and greater survival in pancreatic cancer,76 suggesting that pancreatic tumors systemically alter monocyte trafficking. This evidence concerns the gene CD14 and pancreatic neoplasm.